(Updates to add the company's response in the third paragraph.)
Conmed (CNMD) shares were up 10% in Monday trading after Bloomberg Law reported that the company is exploring options including a potential sale amid takeover interest from private equity firms.
The company is working with its advisers as it weighs its options, Bloomberg said Saturday, citing people familiar with the matter.
Conmed declined to comment when contacted by.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: $41.63, Change: $-0.78, Percent Change: -1.84%